Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
43,411,663
-
Total 13F shares
-
4,466,995
-
Share change
-
+1,101,225
-
Total reported value
-
$40,147,546
-
Price per share
-
$8.99
-
Number of holders
-
34
-
Value change
-
+$9,963,865
-
Number of buys
-
21
-
Number of sells
-
7
Institutional Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q2 2019
As of 30 Jun 2019,
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) was held by
34 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,466,995 shares.
The largest 10 holders included
Nantahala Capital Management, LLC, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, NUVEEN ASSET MANAGEMENT, LLC, Bank of New York Mellon Corp, STIFEL FINANCIAL CORP, and SPHERA FUNDS MANAGEMENT LTD..
This page lists
34
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.